These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 25742563)

  • 21. Cancer stem cells: small subpopulation or evolving fraction?
    Enderling H
    Integr Biol (Camb); 2015 Jan; 7(1):14-23. PubMed ID: 25359461
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vitro and in vivo antiproliferative activity of metformin on stem-like cells isolated from spontaneous canine mammary carcinomas: translational implications for human tumors.
    Barbieri F; Thellung S; Ratto A; Carra E; Marini V; Fucile C; Bajetto A; Pattarozzi A; Würth R; Gatti M; Campanella C; Vito G; Mattioli F; Pagano A; Daga A; Ferrari A; Florio T
    BMC Cancer; 2015 Apr; 15():228. PubMed ID: 25884842
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Investigating the link between epithelial-mesenchymal transition and the cancer stem cell phenotype: A mathematical approach.
    Turner C; Kohandel M
    J Theor Biol; 2010 Aug; 265(3):329-35. PubMed ID: 20648969
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Cellular Origin and Evolution of Breast Cancer.
    Zhang M; Lee AV; Rosen JM
    Cold Spring Harb Perspect Med; 2017 Mar; 7(3):. PubMed ID: 28062556
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Heritable tumor cell division rate heterogeneity induces clonal dominance.
    Palm MM; Elemans M; Beltman JB
    PLoS Comput Biol; 2018 Feb; 14(2):e1005954. PubMed ID: 29432417
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evolutionary dynamics of feedback escape and the development of stem-cell-driven cancers.
    Rodriguez-Brenes IA; Komarova NL; Wodarz D
    Proc Natl Acad Sci U S A; 2011 Nov; 108(47):18983-8. PubMed ID: 22084071
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The telomerase inhibitor imetelstat alone, and in combination with trastuzumab, decreases the cancer stem cell population and self-renewal of HER2+ breast cancer cells.
    Koziel JE; Herbert BS
    Breast Cancer Res Treat; 2015 Feb; 149(3):607-18. PubMed ID: 25627551
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cancer stem cell-driven efficacy of trastuzumab (Herceptin): towards a reclassification of clinically HER2-positive breast carcinomas.
    Martin-Castillo B; Lopez-Bonet E; Cuyàs E; Viñas G; Pernas S; Dorca J; Menendez JA
    Oncotarget; 2015 Oct; 6(32):32317-38. PubMed ID: 26474458
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Microenvironmental variables must influence intrinsic phenotypic parameters of cancer stem cells to affect tumourigenicity.
    Scott JG; Hjelmeland AB; Chinnaiyan P; Anderson AR; Basanta D
    PLoS Comput Biol; 2014 Jan; 10(1):e1003433. PubMed ID: 24453958
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The epigenetic/noncoding origin of tumor dormancy.
    Crea F; Nur Saidy NR; Collins CC; Wang Y
    Trends Mol Med; 2015 Apr; 21(4):206-11. PubMed ID: 25771096
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Therapeutic potential of the metabolic modulator phenformin in targeting the stem cell compartment in melanoma.
    Petrachi T; Romagnani A; Albini A; Longo C; Argenziano G; Grisendi G; Dominici M; Ciarrocchi A; Dallaglio K
    Oncotarget; 2017 Jan; 8(4):6914-6928. PubMed ID: 28036292
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pretumor progression: clonal evolution of human stem cell populations.
    Calabrese P; Tavaré S; Shibata D
    Am J Pathol; 2004 Apr; 164(4):1337-46. PubMed ID: 15039221
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nitric oxide induces cancer stem cell-like phenotypes in human lung cancer cells.
    Yongsanguanchai N; Pongrakhananon V; Mutirangura A; Rojanasakul Y; Chanvorachote P
    Am J Physiol Cell Physiol; 2015 Jan; 308(2):C89-100. PubMed ID: 25411331
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Biphasic modulation of cancer stem cell-driven solid tumour dynamics in response to reactivated replicative senescence.
    Poleszczuk J; Hahnfeldt P; Enderling H
    Cell Prolif; 2014 Jun; 47(3):267-76. PubMed ID: 24666838
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The overshoot and phenotypic equilibrium in characterizing cancer dynamics of reversible phenotypic plasticity.
    Chen X; Wang Y; Feng T; Yi M; Zhang X; Zhou D
    J Theor Biol; 2016 Feb; 390():40-9. PubMed ID: 26626088
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Investigation of solid tumor progression with account of proliferation/migration dichotomy via Darwinian mathematical model.
    Kuznetsov M; Kolobov A
    J Math Biol; 2020 Feb; 80(3):601-626. PubMed ID: 31576418
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tumor dormancy and cancer stem cells: two sides of the same coin?
    Kleffel S; Schatton T
    Adv Exp Med Biol; 2013; 734():145-79. PubMed ID: 23143979
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A hybrid cellular automaton model of clonal evolution in cancer: the emergence of the glycolytic phenotype.
    Gerlee P; Anderson AR
    J Theor Biol; 2008 Feb; 250(4):705-22. PubMed ID: 18068192
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Phenotypic subpopulations of metastatic colon cancer stem cells: genomic analysis.
    Botchkina IL; Rowehl RA; Rivadeneira DE; Karpeh MS; Crawford H; Dufour A; Ju J; Wang Y; Leyfman Y; Botchkina GI
    Cancer Genomics Proteomics; 2009; 6(1):19-29. PubMed ID: 19451087
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Changing mutational and adaptive landscapes and the genesis of cancer.
    Liggett LA; DeGregori J
    Biochim Biophys Acta Rev Cancer; 2017 Apr; 1867(2):84-94. PubMed ID: 28167050
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.